STOCK TITAN

Capricor (NASDAQ: CAPR) EVP sells 25K shares after option exercises

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CAPRICOR THERAPEUTICS, INC. executive vice president and general counsel Karen Krasney reported an exercise-and-sell transaction in company stock. She exercised stock options covering a total of 25,000 shares of common stock at exercise prices of $1.39, $3.74 and $3.18 per share.

On the same day, she sold 25,000 shares of common stock at a weighted average price of $30.1174 per share, with individual trades ranging from $30.00 to $30.31. Following these transactions, she directly holds 30,547 shares of CAPRICOR common stock. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025, indicating the timing was set in advance.

Positive

  • None.

Negative

  • None.
Insider Krasney Karen
Role EVP, GENERAL COUNSEL
Sold 25,000 shs ($753K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 693 $0.00 --
Exercise Stock Option (Right to Buy) 21,488 $0.00 --
Exercise Stock Option (Right to Buy) 2,819 $0.00 --
Exercise Common Stock 693 $1.39 $963.27
Exercise Common Stock 21,488 $3.74 $80K
Exercise Common Stock 2,819 $3.18 $9K
Sale Common Stock 25,000 $30.1174 $753K
Holdings After Transaction: Stock Option (Right to Buy) — 2,807 shares (Direct); Common Stock — 31,240 shares (Direct)
Footnotes (1)
  1. Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.31, inclusive. This option was granted on January 2, 2018 and was previously reported as covering 35,000 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020. Shares vested 1/48th on the first day of each month commencing February 1, 2018. Shares vested 1/48th on the first day of each month commencing February 1, 2021. Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Shares sold 25,000 shares Open-market sale of common stock on March 31, 2026
Weighted average sale price $30.1174 per share Common stock sold in multiple trades between $30.00 and $30.31
Options exercised 25,000 shares Stock options converted to common stock on March 31, 2026
Option exercise prices $1.39, $3.74, $3.18 per share Exercise prices for three stock option tranches
Shares owned after 30,547 shares Direct common stock holdings following the reported transactions
Rule 10b5-1 trading plan regulatory
"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported on Column 4 is the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
reverse stock split financial
"adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019"
A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.
stock option financial
"Stock Option (Right to Buy)"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise or conversion of derivative security financial
"transaction code description: Exercise or conversion of derivative security"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Krasney Karen

(Last)(First)(Middle)
C/O CAPRICOR THERAPEUTICS, INC.
10865 ROAD TO THE CURE, SUITE 150

(Street)
SAN DIEGO CALIFORNIA 92121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CAPRICOR THERAPEUTICS, INC. [ CAPR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, GENERAL COUNSEL
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/31/2026M693A$1.3931,240D
Common Stock03/31/2026M21,488A$3.7452,728D
Common Stock03/31/2026M2,819A$3.1855,547D
Common Stock03/31/2026S(1)25,000D$30.1174(2)30,547D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$1.39(3)03/31/2026M693(3) (4)01/02/2028Common Stock693$02,807D
Stock Option (Right to Buy)$3.7403/31/2026M21,488 (5)01/04/2031Common Stock21,488$074,205D
Stock Option (Right to Buy)$3.1803/31/2026M2,819 (6)01/03/2032Common Stock2,819$081,261D
Explanation of Responses:
1. Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
2. The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.31, inclusive.
3. This option was granted on January 2, 2018 and was previously reported as covering 35,000 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.
4. Shares vested 1/48th on the first day of each month commencing February 1, 2018.
5. Shares vested 1/48th on the first day of each month commencing February 1, 2021.
6. Shares vested 1/48th on the first day of each month commencing February 1, 2022.
/s/ Linda Marban, Attorney-in-Fact04/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CAPR executive Karen Krasney report on this Form 4?

Karen Krasney reported exercising stock options and selling shares of CAPRICOR THERAPEUTICS common stock. She exercised options for 25,000 shares, then sold 25,000 shares in the open market, while retaining a direct ownership stake after the transactions.

How many CAPR shares did Karen Krasney sell and at what price?

She sold 25,000 shares of CAPRICOR common stock at a weighted average price of $30.1174 per share. The sales occurred in multiple trades, with prices ranging from $30.00 to $30.31, as disclosed in the Form 4 footnotes.

Were Karen Krasney’s CAPR share sales made under a Rule 10b5-1 trading plan?

Yes, the Form 4 states the shares were sold under a Rule 10b5-1 trading plan adopted in December 2025. Such plans pre-schedule trades, indicating the timing of these sales was determined in advance rather than decided spontaneously.

How many CAPR shares does Karen Krasney own after these transactions?

After exercising options and selling shares, Karen Krasney directly holds 30,547 shares of CAPRICOR common stock. This post-transaction holding reflects her remaining equity position as reported in the Form 4 following the March 31, 2026 transactions.

What stock options did Karen Krasney exercise in this CAPR Form 4 filing?

She exercised stock options covering 25,000 shares of CAPRICOR common stock in total. The options had exercise prices of $1.39, $3.74 and $3.18 per share, converting previously granted derivative awards into directly held common shares before the related sale.

What is the significance of the weighted average price in Karen Krasney’s CAPR share sale?

The weighted average price of $30.1174 summarizes multiple trades executed between $30.00 and $30.31. It provides a single representative sale price for reporting, while the disclosed range shows the specific prices at which individual trades occurred during the transaction.